Attached files
| file | filename |
|---|---|
| 10-K - NURX PHARMACEUTICALS, INC. | v169993_10k.htm |
| EX-32.2 - NURX PHARMACEUTICALS, INC. | v169993_ex32-2.htm |
| EX-31.2 - NURX PHARMACEUTICALS, INC. | v169993_ex31-2.htm |
| EX-31.1 - NURX PHARMACEUTICALS, INC. | v169993_ex31-1.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the annual report of NuRx Pharmaceuticals, Inc. (the “Company”)
on Form 10-K for the year ending September 30, 2009, as filed with the
Securities and Exchange Commission (the “Report”), I, Harin Padma−Nathan, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:
1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date:
December 29, 2009
|
/s/ Harin Padma−Nathan
|
|
|
Name:
|
Harin
Padma−Nathan
|
|
Title:
|
President
& Chief Executive Officer
|
|
(principal
executive officer)
|
|